Announcements
- 2026.05.28 POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING
- 2026.05.21 VOLUNTARY ANNOUNCEMENT THE TWELVE-MONTH CLINICAL FOLLOW-UP RESULTS FOR LARGE ANNULUS PATIENTS OF LuX-Valve Plus EU TRINITY STUDY PRESENTED AT EuroPCR 2026, DEMONSTRATING LARGE SIZE ADVANTAGES WITH PRODUCT
- 2026.05.07 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
- 2026.04.28 PROXY FORM FOR THE 2025 ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 28 MAY 2026
- 2026.04.28 NOTICE OF 2025 ANNUAL GENERAL MEETING
- 2026.04.28 2025 Annual Report
- 2026.04.28 (1) 2025 REPORT OF THE BOARD OF DIRECTORS (2) 2025 AUDITED FINANCIAL STATEMENTS (3) 2025 ANNUAL REPORT (4) 2025 PROFIT DISTRIBUTION PLAN (5) RE-APPOINTMENT OF AUDITOR (6) REMUNERATION OF DIRECTORS (7) PROPOSED GRANTING OF GENERAL MANDATE TO ISSUE SHARES (8) PROPOSED GRANTING OF GENERAL MANDATE TO REPURCHASE H SHARES AND (9) NOTICE OF 2025 ANNUAL GENERAL MEETING
- 2026.04.09 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
- 2026.03.30 VOLUNTARY ANNOUNCEMENT iJensRobo ROBOT-ASSISTED TTVR SYSTEM COMPLETES FIRST CLINICAL STUDY
- 2026.03.26 APPOINTMENT OF NEW CHIEF FINANCIAL OFFICER; UPDATE ON QUALIFICATION OF COMPANY SECRETARY; AND RESIGNATION OF JOINT COMPANY SECRETARY
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
